Objective： To preliminarily explore the relationship between thrombosis and its associated factors in patients with coronary heart disease （CHD） of turbidity-phlegm blocking syndrome （TPB）, and to study its actin...Objective： To preliminarily explore the relationship between thrombosis and its associated factors in patients with coronary heart disease （CHD） of turbidity-phlegm blocking syndrome （TPB）, and to study its acting mechanism. Methods： Plasma levels of thrombosis-associated factors, including Von Willebrand factor （vWF）, D-dimer, and fibrinogen （Fg）, in 85 patients of CHD with TPB, 93 with CHD of non-TPD, and 89 healthy persons were detected and compared. Results： Levels of the three factors were increased in all the CHD patients, and were higher in TPB patients than in non-TPB patients （P〈0.01 or P〈0.05）. Conclusion： The TPB syndrome in CHD patients was closely related to the blood coagulation-fibrinolytic system; they might be in prethrombosis state, and the plasma levels of vWF, D-dimer, and Fg could be taken as the objective indices for differentiation of TPB syndrome in CHD patients.展开更多
文摘Objective： To preliminarily explore the relationship between thrombosis and its associated factors in patients with coronary heart disease （CHD） of turbidity-phlegm blocking syndrome （TPB）, and to study its acting mechanism. Methods： Plasma levels of thrombosis-associated factors, including Von Willebrand factor （vWF）, D-dimer, and fibrinogen （Fg）, in 85 patients of CHD with TPB, 93 with CHD of non-TPD, and 89 healthy persons were detected and compared. Results： Levels of the three factors were increased in all the CHD patients, and were higher in TPB patients than in non-TPB patients （P〈0.01 or P〈0.05）. Conclusion： The TPB syndrome in CHD patients was closely related to the blood coagulation-fibrinolytic system; they might be in prethrombosis state, and the plasma levels of vWF, D-dimer, and Fg could be taken as the objective indices for differentiation of TPB syndrome in CHD patients.
